These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 24894698)

  • 1. Cerebrospinal fluid inflammatory markers in patients with multiple sclerosis: a pilot study.
    Matejčíková Z; Mareš J; Přikrylová Vranová H; Klosová J; Sládková V; Doláková J; Zapletalová J; Kaňovský P
    J Neural Transm (Vienna); 2015 Feb; 122(2):273-7. PubMed ID: 24894698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebrospinal fluid and serum levels of interleukin-8 in patients with multiple sclerosis and its correlation with Q-albumin.
    Matejčíková Z; Mareš J; Sládková V; Svrčinová T; Vysloužilová J; Zapletalová J; Kaňovský P
    Mult Scler Relat Disord; 2017 May; 14():12-15. PubMed ID: 28619424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebrospinal fluid biomarkers for predicting development of multiple sclerosis in acute optic neuritis: a population-based prospective cohort study.
    Olesen MN; Soelberg K; Debrabant B; Nilsson AC; Lillevang ST; Grauslund J; Brandslund I; Madsen JS; Paul F; Smith TJ; Jarius S; Asgari N
    J Neuroinflammation; 2019 Mar; 16(1):59. PubMed ID: 30857557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune Parameters That Distinguish Multiple Sclerosis Patients from Patients with Other Neurological Disorders at Presentation.
    Mouzaki A; Rodi M; Dimisianos N; Emmanuil A; Kalavrizioti D; Lagoudaki R; Grigoriadis NC; Papathanasopoulos P
    PLoS One; 2015; 10(8):e0135434. PubMed ID: 26317430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokine levels in the cerebrospinal fluid and serum of patients with multiple sclerosis.
    Maimone D; Gregory S; Arnason BG; Reder AT
    J Neuroimmunol; 1991 Apr; 32(1):67-74. PubMed ID: 2002092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrospinal fluid beta-2-microglobulin in multiple sclerosis and AIDS dementia complex.
    Carrieri PB; Indaco A; Maiorino A; Buscaino GA; Ponticiello A; Liberti A; Perrella O
    Neurol Res; 1992 Jun; 14(3):282-3. PubMed ID: 1355285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased levels of IL-23 and osteopontin in serum and cerebrospinal fluid of multiple sclerosis patients.
    Wen SR; Liu GJ; Feng RN; Gong FC; Zhong H; Duan SR; Bi S
    J Neuroimmunol; 2012 Mar; 244(1-2):94-6. PubMed ID: 22329905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased interleukin-6 correlates with myelin oligodendrocyte glycoprotein antibodies in pediatric monophasic demyelinating diseases and multiple sclerosis.
    Horellou P; Wang M; Keo V; Chrétien P; Serguera C; Waters P; Deiva K
    J Neuroimmunol; 2015 Dec; 289():1-7. PubMed ID: 26616865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-15 is elevated in serum and cerebrospinal fluid of patients with multiple sclerosis.
    Rentzos M; Cambouri C; Rombos A; Nikolaou C; Anagnostouli M; Tsoutsou A; Dimitrakopoulos A; Triantafyllou N; Vassilopoulos D
    J Neurol Sci; 2006 Feb; 241(1-2):25-9. PubMed ID: 16316662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrathecal synthesis of beta-2-microglobulin in multiple sclerosis and aseptic meningo-encephalitis.
    Us O; Lolli F; Baig S; Link H
    Acta Neurol Scand; 1989 Dec; 80(6):598-602. PubMed ID: 2694730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Approach to discriminate subgroups in multiple sclerosis with cerebrospinal fluid (CSF) basic inflammation indices and TNF-alpha, IL-1beta, IL-6, IL-8.
    Kleine TO; Zwerenz P; Graser C; Zöfel P
    Brain Res Bull; 2003 Aug; 61(3):327-46. PubMed ID: 12909303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebrospinal Fluid Cytokine Expression Profile in Multiple Sclerosis and Chronic Inflammatory Demyelinating Polyneuropathy.
    Bonin S; Zanotta N; Sartori A; Bratina A; Manganotti P; Trevisan G; Comar M
    Immunol Invest; 2018 Feb; 47(2):135-145. PubMed ID: 29182448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlations between IL-4, IL-12 levels and CCL2, CCL5 levels in serum and cerebrospinal fluid of multiple sclerosis patients.
    Bartosik-Psujek H; Stelmasiak Z
    J Neural Transm (Vienna); 2005 Jun; 112(6):797-803. PubMed ID: 15480850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Th1/Th2 cytokine balance and nitric oxide in cerebrospinal fluid and serum from patients with multiple sclerosis.
    Rodríguez-Sáinz Mdel C; Sánchez-Ramón S; de Andrés C; Rodríguez-Mahou M; Muñoz-Fernández MA
    Eur Cytokine Netw; 2002; 13(1):110-4. PubMed ID: 11956029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple sclerosis - etiology and diagnostic potential.
    Kamińska J; Koper OM; Piechal K; Kemona H
    Postepy Hig Med Dosw (Online); 2017 Jun; 71(0):551-563. PubMed ID: 28665284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebrospinal fluid IL-10 as an early stage discriminative marker between multiple sclerosis and neuro-Behçet disease.
    Belghith M; Bahrini K; Kchaou M; Maghrebi O; Belal S; Barbouche MR
    Cytokine; 2018 Aug; 108():160-167. PubMed ID: 29625335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An extensive search for autoantibodies to myelin basic protein in cerebrospinal fluid of non-multiple-sclerosis patients: implications for the pathogenesis of multiple sclerosis.
    Warren KG; Catz I
    Eur Neurol; 1999; 42(2):95-104. PubMed ID: 10473981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased level of cerebrospinal fluid beta 2-microglobulin is related to neurologic impairment in multiple sclerosis.
    Bjerrum OW; Bach FW; Zeeberg I
    Acta Neurol Scand; 1988 Jul; 78(1):72-5. PubMed ID: 3051857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sulfatide isoform pattern in cerebrospinal fluid discriminates progressive MS from relapsing-remitting MS.
    Novakova L; Singh AK; Axelsson M; Ståhlman M; Adiels M; Malmeström C; Zetterberg H; Borén J; Lycke J; Cardell SL; Blomqvist M
    J Neurochem; 2018 Aug; 146(3):322-332. PubMed ID: 29676479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet-derived growth factor predicts prolonged relapse-free period in multiple sclerosis.
    Stampanoni Bassi M; Iezzi E; Marfia GA; Simonelli I; Musella A; Mandolesi G; Fresegna D; Pasqualetti P; Furlan R; Finardi A; Mataluni G; Landi D; Gilio L; Centonze D; Buttari F
    J Neuroinflammation; 2018 Apr; 15(1):108. PubMed ID: 29655371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.